Danaher Co. (NYSE:DHR) Stake Cut by Copperwynd Financial LLC

Copperwynd Financial LLC cut its position in shares of Danaher Co. (NYSE:DHR) by 13.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,097 shares of the conglomerate’s stock after selling 475 shares during the quarter. Copperwynd Financial LLC’s holdings in Danaher were worth $711,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DHR. FMR LLC lifted its stake in Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. Raymond James Financial Inc. bought a new position in Danaher during the fourth quarter worth $391,172,000. Van ECK Associates Corp lifted its stake in Danaher by 6,862.7% in the fourth quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate’s stock valued at $213,452,000 after buying an additional 916,513 shares during the last quarter. Parnassus Investments LLC lifted its stake in Danaher by 31.8% in the fourth quarter. Parnassus Investments LLC now owns 3,105,388 shares of the conglomerate’s stock valued at $712,842,000 after buying an additional 749,136 shares during the last quarter. Finally, Proficio Capital Partners LLC lifted its stake in Danaher by 29,287.7% in the fourth quarter. Proficio Capital Partners LLC now owns 588,929 shares of the conglomerate’s stock valued at $135,189,000 after buying an additional 586,925 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Price Performance

NYSE:DHR opened at $211.09 on Friday. The business’s 50-day moving average price is $220.07 and its 200 day moving average price is $240.82. The firm has a market cap of $150.87 billion, a P/E ratio of 39.98, a PEG ratio of 2.66 and a beta of 0.82. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company posted $2.09 EPS. As a group, sell-side analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.24%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Citigroup cut their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Jefferies Financial Group cut their target price on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Finally, Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research note on Friday. Six investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $277.76.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.